刊物主题:Molecular Medicine; Human Genetics; Cancer Research; Laboratory Medicine; Pharmacotherapy;
出版者:Springer International Publishing
ISSN:1179-2000
卷排序:20
文摘
IntroductionAssessment of KIT/PDGFRA mutations is essential for therapeutic decision making in patients with gastrointestinal stromal tumor (GIST). Blood-derived circulating tumor DNA can provide molecular information representative of the tumor tissue.